Details for Patent: 10,206,879

Which drugs does patent 10,206,879 protect, and when does it expire?

Patent 10,206,879 protects CRESEMBA and is included in one NDA.

Protection for CRESEMBA has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.

This patent has eight patent family members in seven countries.

Summary for Patent: 10,206,879

Patent landscape, scope, and claims:

Title:	Active ingredient containing stabilised solid forms and method for the production thereof
Abstract:	The invention relates to solid medicinal forms containing at least one active ingredient and at least one pharmaceutically compatible, water soluble drying agent which is selected from the group consisting of trimagnesium dicitrate and/or calcium chloride, the solid medicinal form having a drying loss of at most 6% and a relative equilibrium moisture content of 25% or less. The invention also relates to solid medicinal forms containing a moisture-sensitive active ingredient and trimagnesium dicitrate.
Inventor(s):	Gruber; Peter (Merzhausen, DE), Spickermann; Dirk (Staufen, DE)
Assignee:	Losan Pharma GmbH (Neuenburg, DE)
Application Number:	15/705,599
Patent Claim Types: see list of patent claims	Compound; Dosage form;

Drugs Protected by US Patent 10,206,879

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Astellas	CRESEMBA	isavuconazonium sulfate	CAPSULE;ORAL	207500-002	Nov 22, 2022		RX	Yes	No	10,206,879*PED				Y
Astellas	CRESEMBA	isavuconazonium sulfate	CAPSULE;ORAL	207500-001	Mar 6, 2015		RX	Yes	Yes	10,206,879*PED				Y

Foreign Priority and PCT Information for Patent: 10,206,879

Foriegn Application Priority Data
Foreign Country	Foreign Patent Number	Foreign Patent Date
	06020008	Sep 25, 2006

International Family Members for US Patent 10,206,879

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Austria	E459342
Australia	2007302320
Canada	2663941
Germany	502007003037